Jupiter Neurosciences, Inc. (JUNS): Gross Profit

Annual figures by period end, from SEC filings.

$17.6K

Year ended 2025-12-31

Period ended	Gross Profit	Change YoY	Source filing
2025-12-31	$17.6K	n/a	2026-04-01, From 2025-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Gross Profit	Change YoY
Jupiter Neurosciences, Inc. (JUNS)	2025-12-31	$17.6K	n/a
Skinvisible, Inc. (SKVI)	2025-12-31	$20.0K	0.0%
Bioadaptives, Inc. (BDPT)	2025-12-31	$12.5K	+210.1%
PRF Technologies Ltd. (PRFX)	2025-12-31	-$53.0K	n/a
Impact Biomedical Inc. (IBO)	2025-12-31	-$392.0K	n/a
HCW Biologics Inc. (HCWB)	2025-12-31	$10.8K	-98.9%
Silo Pharma, Inc. (SILO)	2025-12-31	$27.8K	-58.0%
Aspire Biopharma Holdings, Inc. (ASBP)	2025-12-31	-$116	n/a
One World Products, Inc. (OWPC)	2024-12-31	$3.9K	n/m

Compare JUNS, SKVI, BDPT, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗